Mode
Text Size
Log in / Sign up
Phase 1 N=62 Randomized Quadruple-blind Treatment

Pectointercostal Fascial Plane Block (PIFB) Alone Versus PIFB With Rectus Sheath Block (RSB) in Cardiac Surgery

Coronary Artery Disease · Postoperative Pain · Respiratory Failure

Enrolled (actual)
62
Serious AEs
1.6%
Results posted
Nov 2025
Primary outcome: Primary: Pain Scores at Rest Within the First 24 Hours After Extubation — 79.25; 102 Numeric rating score * hours.

Study Design & Population

Study type
Interventional
Phase
Phase 1
Interventions
Rectus sheath block with bupivacaine (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Medical College of Wisconsin
Primary completion
Nov 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Pain Scores at Rest Within the First 24 Hours After Extubation
79.25; 102
PRIMARY
Pain Scores With Deep Breathing Within the First 24 Hours After Extubation
141.5; 144
PRIMARY
Total Cumulative Opioid Consumption
96.75; 95
PRIMARY
Total Cumulative Opioid Consumption
96.75; 95
SECONDARY
Time From ICU Arrival to Liberation From Mechanical Ventilation
3.87; 3.87
SECONDARY
Vital Capacity Change From Baseline on Incentive Spirometry
.32; .30
SECONDARY
Vital Capacity Change From Baseline on Incentive Spirometry
.32; .30
SECONDARY
Vital Capacity Change From Baseline on Incentive Spirometry
.32; .30
SECONDARY
Vital Capacity Change From Baseline on Incentive Spirometry
.32; .30
SECONDARY
QoR-15 (Quality of Recovery) Score
83; 79.5
SECONDARY
ICU Length of Stay
20.69; 25.77
SECONDARY
Hospital Length of Stay
97.21; 97.31

Summary

The purpose of this study is to determine if ultrasound-guided bilateral pectointercostal fascial plane blocks with bilateral rectus sheath blocks block decrease pain scores, decrease opioid consumption, improve respiratory function, and improve quality of recovery in patients recovering from elective cardiac surgery involving primary median sternotomy and mediastinal chest tubes in comparison to pectointercostal fascial plane blocks alone.

Eligibility Criteria

Inclusion Criteria

  • Subjects scheduled for cardiac surgery involving primary median sternotomy and mediastinal chest tubes.
  • Age 18-85 years of age
  • BMI 18-50 kg/m2
  • Weight > 60 kg

Exclusion Criteria

  • Left ventricular ejection fraction (LVEF) 20 mg) in the past three months
  • Severe pulmonary or hepatic disease
  • Neurological deficit or disorder
  • Suspected or known addiction to or abuse of illicit drug(s), prescription medicine(s), or alcohol within the past two years
  • Uncontrolled anxiety, schizophrenia, or other severe psychiatric disorder
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04908449). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search